(2011). "Normalized names for clini- cal drugs: RxNorm at 6 years." Journal of the American Med- ical Informatics Association18(3).Nelson SJ, Zeng K, Kilbourne J, Powell T, Moore R. Normalized names for clinical drugs: RxNorm at 6 years. J Am Med Inform Assoc. 2011;18:441-8....
& Fahr, A. Drug delivery strategies for poorly water-soluble drugs: the industrial perspective. Expert Opin. Drug Deliv. 8, 1481–1500 (2011). Article CAS Google Scholar Rogueda, P. Novel hydrofluoroalkane suspension formulations for respiratory drug delivery. Expert Opin. Drug Deliv. 2, ...
And third, the FDA should give unique names to each biosimilar that comes on the market. This will help avoid any confusion between doctors, pharmacists, and patients over what medication the patient is taking. And it will help trace any biosimilar drug on the market that begins to cause ...
CTRPv2 and GDSC often use slightly different names for the same drugs and cell lines, so these identifiers were matched between the two datasets using the harmonized identifiers provided by Ling et al.12. The code used to do this is included in the “Harmonizing GDSC and CTRPv2” folder of...
See all videos for this article pharmacology, branch of medicine that deals with the interaction of drugs with the systems and processes of living animals, in particular, the mechanisms of drug action as well as the therapeutic and other uses of the drug. The first Western pharmacological ...
OBJECTIVE This paper describes (DrugEx), which extracts drugs and their attributes from clinical free-text notes. The study aims to evaluate the feasibility of using NLP and deep learning approaches for extracting and linking drug-associated attributes. It also presents an extensive error analysis ...
RXNORM, Normalized names for clinical drugs, 2017. Retrieved from https://bioportal.bioontology.org/ontologies/RXNORM. Google Scholar [50] G.K. Savova, J. Fan, Z. Ye, S.P. Murphy, J. Zheng, C.G. Chute, I.J. Kullo Discovering peripheral arterial disease cases from radiology notes us...
(due to either containing multiple drugs or drugs with multiple active ingredients) are also filtered out. As an additional quality control step, we remove intervention arms that contain plus (“+”) signs in their names that usually indicate combination treatments that RxNorm is not always able...
Deshmukh AD, Kesselheim AS, Rome BN. Timing of confirmatory trials for drugs granted accelerated approval based on surrogate measures from 2012 to 2021. JAMA Health Forum. 2023;4(3):e230217. doi:10.1001/jamahealthforum.2023.0217 ...
(eTable 1 inSupplement 1). The PMIDs related to drugs were identified by searching for the brand name, active pharmaceutical ingredient, or company chemical identifiers. The PMIDs related to targets were identified by searching for the drug target names and appropriate Medical Subject Heading ...